BSE Live
Nov 10, 16:01Prev. Close
106.65
Open Price
106.05
Bid Price (Qty.)
100.00 (1)
Offer Price (Qty.)
117.25 (22)
NSE Live
Nov 10, 15:53Prev. Close
106.11
Open Price
105.54
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Brooks Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -13.84 | -9.20 | -8.53 | 1.03 | 6.57 | |
| Diluted EPS (Rs.) | -13.84 | -9.20 | -8.53 | 1.03 | 6.57 | |
| Cash EPS (Rs.) | -7.18 | -5.13 | -4.55 | 2.06 | 7.29 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 39.84 | 64.96 | 70.72 | 79.25 | 75.40 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 39.84 | 64.96 | 70.72 | 79.25 | 75.40 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 28.21 | 34.00 | 34.42 | 35.55 | 49.43 | |
| PBDIT/Share (Rs.) | -1.42 | -3.39 | -5.37 | 3.19 | 7.81 | |
| PBIT/Share (Rs.) | -4.11 | -7.40 | -9.35 | 2.16 | 7.10 | |
| PBT/Share (Rs.) | -5.47 | -9.23 | -10.83 | 1.53 | 6.68 | |
| Net Profit/Share (Rs.) | -9.87 | -9.15 | -8.53 | 1.03 | 6.57 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -5.04 | -9.96 | -15.58 | 8.97 | 15.80 | |
| PBIT Margin (%) | -14.58 | -21.77 | -27.15 | 6.06 | 14.35 | |
| PBT Margin (%) | -19.39 | -27.16 | -31.47 | 4.31 | 13.52 | |
| Net Profit Margin (%) | -34.97 | -26.90 | -24.79 | 2.89 | 13.29 | |
| Return on Networth / Equity (%) | -24.76 | -14.08 | -12.06 | 1.29 | 8.71 | |
| Return on Capital Employed (%) | -9.06 | -9.94 | -11.44 | 1.19 | 8.53 | |
| Return on Assets (%) | -15.44 | -8.81 | -7.99 | 1.01 | 6.97 | |
| Total Debt/Equity (X) | 0.24 | 0.27 | 0.22 | 0.10 | 0.05 | |
| Asset Turnover Ratio (%) | 44.14 | 32.76 | 32.26 | 35.05 | 52.45 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.83 | 0.67 | 0.76 | 0.90 | 1.17 | |
| Quick Ratio (X) | 0.53 | 0.46 | 0.48 | 0.58 | 0.93 | |
| Inventory Turnover Ratio (X) | 5.06 | 5.47 | 4.88 | 7.47 | 11.96 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 60.28 | 111.06 | 152.70 | 230.15 | 142.52 | |
| EV/Net Operating Revenue (X) | 0.86 | 2.02 | 2.74 | 4.00 | 1.78 | |
| EV/EBITDA (X) | -17.14 | -20.24 | -17.58 | 44.57 | 11.27 | |
| MarketCap/Net Operating Revenue (X) | 0.54 | 1.57 | 2.32 | 3.81 | 1.74 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.38 | 0.82 | 1.13 | 1.71 | 1.14 | |
| Price/Net Operating Revenue | 0.54 | 1.57 | 2.32 | 3.81 | 1.74 | |
| Earnings Yield | -0.64 | -0.17 | -0.11 | 0.01 | 0.08 |
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
04.03.2025
Brooks Labs Consolidated December 2024 Net Sales at Rs 38.45 crore, up 76.8% Y-o-Y
18.11.2024
Brooks Labs Standalone September 2024 Net Sales at Rs 20.79 crore, down 14.49% Y-o-Y
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
04.03.2025
Brooks Labs Consolidated December 2024 Net Sales at Rs 38.45 crore, up 76.8% Y-o-Y
18.11.2024
Brooks Labs Standalone September 2024 Net Sales at Rs 20.79 crore, down 14.49% Y-o-Y